Study objective-The aim was to estimate the likely burden of cervical cancer in New Zealand over the next two decades, according to whether cervical screening services are made more effective.
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Design-The study was based on national mortality and incidence data for the periods and 1954-86, respectively. An ageperiod-cohort model was used to estimate the contributions of age, time period, and birth cohort effects to the occurrence of cervical cancer. Using age specific estimates of the future female population of New Zealand, projections of cervical cancer mortality and incidence until the year 2008 were derived from the model. Projections were made assuming either that screening services will not be improved, or that an immediate improvement in the organisation of screening will lead to a decline in period effects for incidence of 15% per five year time period (with a slightly delayed effect on mortality). It was also assumed either that the risk in new birth cohorts will be similar to that in recent cohorts, or that their risk will be halved as a result of changes in sexual behaviour (due to education about AIDS or other factors).
Combining these assumptions produced four sets of estimates, reflecting a range of possible scenarios.
Setting-Both the data used and the projections obtained related to the entire population of New Zealand women.
Main results-For both mortality and incidence, projections were made of age specific rates, cumulative rates, and absolute numbers of deaths or new cases. With the first assumption about new birth cohorts, it was estimated that both mortality and incidence rates will increase if screening services are are not improved. In absolute terms, the present 100 deaths per year could increase to about 148 deaths per year, while there could be a much larger increase in incidence from 235 improvements in mortality from a better screening service occur later than reductions in the incidence of cervical cancer, the period value for the first future time period in estimating mortality rates, 1989-93, was assumed to be only 7-50' lower than unity (with successive 1500 reductions thereafter). These future period values represent a 43 %o reduction in mortality and a 48 0 reduction in incidence from improvements in screening over a 20 year period. Such reductions in mortality and incidence from screening are similar to those observed in Finland and Sweden but not as great as those observed in Iceland. [11] [12] The age values obtained from the statistical models of past incidence and mortality rates remained the same for future time periods. Combinations of the two future time period values and the two future birth cohort values produced four projections for both mortality and incidence.
Recombining the age values with estimated future birth cohort values and time period values produced estimates of future mortality and incidence rates of cervical cancer in New Zealand. Using projections of the population that assume low fertility, medium short term migration and zero long term migration,'3 future numbers of deaths and women developing cervical cancer were estimated. For the 1984-88 time period the mortality and incidence rates used were those observed for the 1984-87 and 1984-86 periods, respectively. The cumulative mortality and incidence rates up to age 75 years were calculated for previous years and compared with those predicted for the future. Comparison of projections PlCl with P1C2 or cancer remains high for future generations but P2C1 with P2C2, for both cumulative mortality screening is made more effective, about 220 and incidence rates, suggests that the influence of 
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